Skip to main content
Clinical Trials/CTRI/2020/05/025229
CTRI/2020/05/025229
Not yet recruiting
Phase 1

Evaluation of efficacy of Intranasal Midazolam and its combination with Intranasal Ketamine as premedication of children scheduled for elective surgery.

Dr Aarti Agarwal0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Aarti Agarwal
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Aarti Agarwal

Eligibility Criteria

Inclusion Criteria

  • Children between 2\-12 years of age
  • Weight \< 20 kg
  • ASA I and II
  • Scheduled for elective surgery

Exclusion Criteria

  • 1\. Patientâ??s parent consent refusal
  • 2\. Patients with known allergy to any medications, running nose, upper respiratory tract infections, mental retardation, or neurobehavioral problems.
  • 3\. Emergency surgery
  • 4\. Patient belonging to ASA 3 or 4 group.

Outcomes

Primary Outcomes

Not specified

Similar Trials